Lupin Limited has informed the Exchange regarding a press release dated May 10, 2021, titled "Lupin enters into Voluntary Licensing Agreement with Lilly to Expand Access for COVID-19 Treatment in India.".
Lupin Limited has informed the Exchange regarding a press release dated May 10, 2021, titled "Lupin enters into Voluntary Licensing Agreement with Lilly to Expand Access for COVID-19 Treatment in India.".